These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7525391)

  • 1. Molecular and cellular parameters controlling the immunogenicity of foreign B- or T-cell epitopes expressed by recombinant vectors.
    Leclerc C; Lo-Man R; Fayolle C; Charbit A; Clément JM; Martineau P; O'Callaghan D; Hofnung M
    Dev Biol Stand; 1994; 82():193-9. PubMed ID: 7525391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and immune response to foreign epitopes in bacteria. Perspectives for live vaccine development.
    Charbit A; Newton SM; Klebba PE; Clément JM; Fayolle C; Lo-Man R; Leclerc C; Hofnung M
    Behring Inst Mitt; 1997 Feb; (98):135-42. PubMed ID: 9382734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics.
    Leclerc C; Charbit A; Martineau P; Deriaud E; Hofnung M
    J Immunol; 1991 Nov; 147(10):3545-52. PubMed ID: 1719080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies.
    LeClerc C; Martineau P; Van der Werf S; Deriaud E; Duplay P; Hofnung M
    J Immunol; 1990 Apr; 144(8):3174-82. PubMed ID: 2157762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to hybrid maltose-binding proteins.
    O'Callaghan D; Martineau P; Fayolle C; Leclerc C; Guillet JG; Charbit A; Hofnung M
    Vaccine; 1993; 11(2):140-2. PubMed ID: 7679863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.
    Martineau P; Guillet JG; Leclerc C; Hofnung M
    Gene; 1992 Apr; 113(1):35-46. PubMed ID: 1373395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins.
    Leclerc C; Lo-Man R; Charbit A; Martineau P; Clément JM; Hofnung M
    Int Rev Immunol; 1994; 11(2):123-32. PubMed ID: 7519229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope.
    Lo-Man R; Martineau P; Hofnung M; Leclerc C
    Eur J Immunol; 1993 Nov; 23(11):2998-3002. PubMed ID: 8223877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein.
    Lo-Man R; Martineau P; Manoury-Schwartz B; Hofnung M; Leclerc C
    Int Immunol; 1996 Aug; 8(8):1245-55. PubMed ID: 8918694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition.
    Lo-Man R; Martineau P; Betton JM; Hofnung M; Leclerc C
    J Immunol; 1994 Jun; 152(12):5660-9. PubMed ID: 7515911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes.
    Brumeanu TD; Bot A; Bona CA; Dehazya P; Wolf I; Zaghouani H
    Immunotechnology; 1996 Jun; 2(2):85-95. PubMed ID: 9373317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular processing and presentation of T cell epitopes, expressed by recombinant Escherichia coli and Salmonella typhimurium, to human T cells.
    Verjans GM; Janssen R; UytdeHaag FG; van Doornik CE; Tommassen J
    Eur J Immunol; 1995 Feb; 25(2):405-10. PubMed ID: 7533085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle.
    Lo-Man R; Langeveld JP; Dériaud E; Jehanno M; Rojas M; Clément JM; Meloen RH; Hofnung M; Leclerc C
    Infect Immun; 2000 Jun; 68(6):3079-89. PubMed ID: 10816447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular targeting in the expression of foreign polypeptides in bacteria.
    Clément JM; Charbit A; Leclerc C; Martineau P; Muir S; O'Callaghan D; Popescu O; Szmelcman S; Hofnung M
    Antonie Van Leeuwenhoek; 1992 Feb; 61(2):143-52. PubMed ID: 1580616
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
    Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium.
    Lo-Man R; Martineau P; Dériaud E; Newton SM; Jehanno M; Clément JM; Fayolle C; Hofnung M; Leclerc CD
    Infect Immun; 1996 Nov; 64(11):4424-32. PubMed ID: 8890187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
    Galen JE; Zhao L; Chinchilla M; Wang JY; Pasetti MF; Green J; Levine MM
    Infect Immun; 2004 Dec; 72(12):7096-106. PubMed ID: 15557633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of purified recombinant Bet v 1 with authentic N-terminus, cloned in fusion with maltose-binding protein.
    Spangfort MD; Ipsen H; Sparholt SH; Aasmul-Olsen S; Larsen MR; Mørtz E; Roepstorff P; Larsen JN
    Protein Expr Purif; 1996 Nov; 8(3):365-73. PubMed ID: 8936599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a recombinant Toxoplasma gondii ROP2 fragment as a fusion protein in bacteria circumvents insolubility and proteolytic degradation.
    Jacquet A; Daminet V; Haumont M; Garcia L; Chaudoir S; Bollen A; Biemans R
    Protein Expr Purif; 1999 Dec; 17(3):392-400. PubMed ID: 10600457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.